Replies to post #140172 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

CNS trial decisions were made w/o using any new FDA precision medicine guidance (see today's BIIB withdrawl as a possible example). A search provided by investor shows continued use of existing trials. There will be a lot of "What If" being done before this is over. Being first is never easy.